Skip to main content
. 2008 Mar;3(2):423–430. doi: 10.2215/CJN.02010507

Table 3.

Significant differences in cytokine ratios between HD patients and control subjects

Parameter HD (n = 134)
Controls (n = 150)
Pa
n % n %
IL-4/IL-6
    <0.008 43 32.1 2 1.3 <0.0001
    0.008 to 0.039 47 35.1 24 16.0
    ≥0.04 44 32.8 124 82.7
IL-10/IL-6
    <0.008 44 32.8 0 <0.0001
    0.008 to 0.038 45 33.6 4 2.7
    ≥0.039 45 33.6 146 97.3
(IL-4+IL-10)/(IL-6+TNF-α)
    <0.009 44 32.8 0 <0.0001
    0.009 to 0.047 46 34.3 17 11.3
    ≥0.048 44 32.8 133 88.7
(IL-4+IL-10)/IL-6
    <0.018 44 32.8 0 <0.0001
    0.018 to 0.116 46 34.3 9 6.0
    ≥0.117 44 32.8 141 94.0
(IL-4+IL-6+IL-10)/(IL-2+IFN-γ)
    <0.80 44 32.8 123 82.0 <0.0001
    0.80 to 2.21 45 33.6 19 12.7
    ≥2.22 45 33.6 8 5.3
a

Adjusted for age and gender.